Market Closed

MAZE
Maze Therapeutics
$ 34.33
-4.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago

Maze Therapeutics News

Latest Maze Therapeutics Stock News & MAZE Headlines

Maze Therapeutics Reports Third Quarter 2026 Financial Results and Recent Highlights
5 days ago | globenewswire.com
Wall Street Analysts Predict a 93.92% Upside in Maze Therapeutics, Inc. (MAZE): Here's What You Should Know
11 days ago | zacks.com
Maze Therapeutics to Participate in Upcoming Investor Conferences
12 days ago | globenewswire.com
What Makes Maze Therapeutics, Inc. (MAZE) a New Buy Stock
a month ago | zacks.com
How Much Upside is Left in Maze Therapeutics, Inc. (MAZE)? Wall Street Analysts Think 123.39%
a month ago | zacks.com
Maze Therapeutics (NASDAQ:MAZE) vs. Nektar Therapeutics (NASDAQ:NKTR) Financial Analysis
a month ago | defenseworld.net
Head to Head Survey: Maze Therapeutics (NASDAQ:MAZE) and Cytokinetics (NASDAQ:CYTK)
a month ago | defenseworld.net
Maze Therapeutics to Present Data from MZE829 and MZE782 Programs at ASN Kidney Week 2026
a month ago | globenewswire.com
Maze Therapeutics, Inc. (NASDAQ:MAZE) Stock Has Consensus Price Target of $63.40
a month ago | defenseworld.net
Maze Therapeutics (NASDAQ:MAZE) Shares Climb 4.5% – Still a Buy?
2 months ago | defenseworld.net
Load More

Download App

Keep track of your holdings and explore over 40,000 cryptocurrencies

oinCodex Android App
CoinCodex Mobile App
Market Closed

MAZE
Maze Therapeutics
$ 34.33
-4.88%   Last 24H
 
Trading with leverage comes with a high risk and may not be suitable for everyone.
   
Trading with leverage comes with a high risk and may not be suitable for everyone.
Portfolio
Updated a day ago